To gain a deeper understanding of the potential usefulness of ev-PSA in monitoring responses to different therapies and detecting tumor progression, the first and most essential step would be to recruit a larger cohort of patients, as this would enhance both the statistical power and the generalizability of the findings. The gene discussed is KLK3; the disease is neoplasm.